Literature DB >> 26793376

Prolonged dual antiplatelet therapy in renal failure: a challenging trade-off.

Matthias Bossard1, Raban Jeger1.   

Abstract

Entities:  

Year:  2015        PMID： 26793376      PMCID： PMC4703638          DOI： 10.3978/j.issn.2072-1439.2015.12.44

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

Review 1.  Antithrombotic therapy in patients with chronic kidney disease.

Authors:  Davide Capodanno; Dominick J Angiolillo
Journal:  Circulation       Date:  2012-05-29       Impact factor: 29.690

Review 2.  Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper.

Authors:  Giuseppe Patti; Raffaele De Caterina; Rosanna Abbate; Felicita Andreotti; Luigi Marzio Biasucci; Paolo Calabrò; Gabriele Cioni; Giovanni Davì; Germano Di Sciascio; Enrica Golia; Paolo Golino; Gelsomina Malatesta; Fabio Mangiacapra; Rossella Marcucci; Annunziata Nusca; Vito Maurizio Parato; Vittorio Pengo; Domenico Prisco; Fabio Pulcinelli; Giulia Renda; Elisabetta Ricottini; Benedetta Ruggieri; Francesca Santilli; Francesco Sofi; Marco Zimarino
Journal:  Eur Heart J       Date:  2014-07-14       Impact factor: 29.983

3.  Long-term use of ticagrelor in patients with prior myocardial infarction.

Authors:  Marc P Bonaca; Deepak L Bhatt; Marc Cohen; Philippe Gabriel Steg; Robert F Storey; Eva C Jensen; Giulia Magnani; Sameer Bansilal; M Polly Fish; Kyungah Im; Olof Bengtsson; Ton Oude Ophuis; Andrzej Budaj; Pierre Theroux; Mikhail Ruda; Christian Hamm; Shinya Goto; Jindrich Spinar; José Carlos Nicolau; Robert G Kiss; Sabina A Murphy; Stephen D Wiviott; Peter Held; Eugene Braunwald; Marc S Sabatine
Journal:  N Engl J Med       Date:  2015-03-14       Impact factor: 91.245

4.  Relation between kidney function, proteinuria, and adverse outcomes.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

5.  Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease.

Authors:  Gjin Ndrepepa; Franz-Josef Neumann; Salvatore Cassese; Massimiliano Fusaro; Ilka Ott; Stefanie Schulz; Petra Hoppmann; Gert Richardt; Karl-Ludwig Laugwitz; Heribert Schunkert; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2013-10-04       Impact factor: 5.460

6.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

Review 7.  Anticoagulant and antiplatelet therapy in patients with chronic kidney disease: risks versus benefits review.

Authors:  John P Harmon; Danielle L Zimmerman; Deborah L Zimmerman
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

8.  The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.

Authors:  Patricia J M Best; Steven R Steinhubl; Peter B Berger; Arijit Dasgupta; Danielle M Brennan; Lynda A Szczech; Robert M Califf; Eric J Topol
Journal:  Am Heart J       Date:  2008-02-21       Impact factor: 4.749

9.  In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.

Authors:  Faisal Latif; Neal S Kleiman; David J Cohen; Michael J Pencina; Chen-Hsing Yen; Donald E Cutlip; David J Moliterno; Deborah Nassif; John J Lopez; Jorge F Saucedo
Journal:  JACC Cardiovasc Interv       Date:  2009-01       Impact factor: 11.195

Review 10.  Haemostasis in chronic kidney disease.

Authors:  Jens Lutz; Julia Menke; Daniel Sollinger; Helmut Schinzel; Klaus Thürmel
Journal:  Nephrol Dial Transplant       Date:  2013-10-16       Impact factor: 5.992
View more
  1 in total

1.  Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Xiaole Su; Bingjuan Yan; Lihua Wang; Jicheng Lv; Hong Cheng; Yipu Chen
Journal:  BMC Nephrol       Date:  2019-08-07       Impact factor: 2.388
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.